Search This Blog

Thursday, September 17, 2026

Aethlon Medical to merge all-stock with North Immunology

 

leaving its holders ~4.75% of renamed Nasdaq-listed NRTX company

  • Transaction structured as a definitive all-stock merger with privately held North Immunology.
  • $180 million private placement will accompany the merger to fund the combined North Immunology Inc. entity.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)